# [18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma

> **NCT06428708** · EARLY_PHASE1 · RECRUITING · sponsor: **Western University** · enrollment: 30 (estimated)

## Conditions studied

- Metastatic Clear Cell Renal Cell Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** [18F] PSMA-1007 PET/CT

## Key facts

- **NCT ID:** NCT06428708
- **Lead sponsor:** Western University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-24
- **Primary completion:** 2024-12
- **Final completion:** 2025-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06428708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06428708, "[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06428708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*